Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles-Reference-Cited by-同舟云学术

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Published:2019-04 Issue:2 Volume:19 Page:e306-e318
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Vernieri Claudio,Prisciandaro Michele,Milano Monica,Cona Maria Silvia,Maggi Claudia,Brambilla Marta,Mennitto Alessia,Fabbroni Chiara,Farè Elena,Cresta Sara^ORCID,Celio Luigi,Mariani Gabriella,Bianchi Giulia,Capri Giuseppe,de Braud Filippo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Cancer Facts & Figures 2017,2017

2. Facts and controversies in systemic treatment of metastatic breast cancer;Bernard-Marty;Oncologist,2004

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials;Lancet,2012

4. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management;Curigliano;CA Cancer J Clin,2016

5. The molecular genetics of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis;Cliff;Crit Rev Oncol Hematol,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer;International Journal of Molecular Sciences;2024-03-17

2. Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy;Medical Oncology;2023-12-16

3. In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents;International Journal of Molecular Sciences;2023-09-06

4. Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison;Clinical Breast Cancer;2023-04

5. Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer;CA: A Cancer Journal for Clinicians;2023-03-20